Bristol Myers Squibb (BMY)
(Delayed Data from NYSE)
$44.23 USD
+0.92 (2.12%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $44.29 +0.06 (0.14%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth D Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Bristol Myers Squibb Company has a market cap of $88.14B, which represents its share price of $43.31 multiplied by its outstanding shares number of 2.04B. As a large-cap company, BMY's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BMY 44.23 +0.92(2.12%)
Will BMY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BMY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BMY
Economy Heating Up on PCE for June
Bristol Myers Beats on Q2 Earnings and Sales, Raises '25 Sales View
BMY: What are Zacks experts saying now?
Zacks Private Portfolio Services
PCE Comes in Warmer Than Expected
Bristol Myers (BMY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Top Estimates
Other News for BMY
Earnings Scorecard: 18 out of 21 healthcare firms beat earnings forecast this week
Notable healthcare headlines for the week: Trump’s ultimatum to big pharma, Novo Nordisk, UnitedHealth and Moderna in focus
Bristol Myers (BMY) Price Target Reduced by Bernstein After Q2 Report
Bristol Myers price target lowered by $4 at Bernstein, here's why
Bristol-Myers Squibb: Declines Have Gone Too Far